A detailed history of National Bank Of Canada transactions in Mannkind Corp stock. As of the latest transaction made, National Bank Of Canada holds 21,553 shares of MNKD stock, worth $147,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,553
Previous 21,553 -0.0%
Holding current value
$147,638
Previous $135,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.01 - $6.7 $13,942 - $18,646
2,783 Added 14.83%
21,553 $135,000
Q2 2024

Aug 02, 2024

SELL
$4.05 - $5.43 $18,225 - $24,435
-4,500 Reduced 19.34%
18,770 $97,000
Q4 2021

Jan 24, 2022

BUY
$4.05 - $5.37 $94,243 - $124,959
23,270 New
23,270 $101,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.